Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Heron Therapeutics, Inc. is a biotechnology company focused on developing and commercializing innovative therapies for acute care and oncology patients. Its portfolio includes products like ZYNRELEF for postoperative pain, APONVIE for nausea, and antiemetics CINVANTI and SUSTOL. The company leverages proprietary drug delivery technology, operates in regulated markets, and relies on third-party manufacturing and patent protections to maintain its competitive position.
This description was generated via AI from an annual report. Updated about 1 year ago.